Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Labeling of Certain Beers Subject to the Labeling Jurisdiction of the Food and Drug Administration, 43335-43337 [2012-18028]
Download as PDF
43335
Federal Register / Vol. 77, No. 142 / Tuesday, July 24, 2012 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Administration on Intellectual and
Developmental Disabilities; Agency
Information Collection Activities;
Proposed Collection; Comment
Request; Financial Status Reporting
Form for State Councils on
Developmental Disabilities
Administration for Community
Living, Administration on Intellectual
and Developmental Disabilities, HHS.
ACTION: Notice.
AGENCY:
For the program of the State
Councils on Developmental Disabilities,
SUMMARY:
funds are awarded to State agencies
contingent on fiscal requirements in
subtitle B of the Developmental
Disabilities Assistance and Bill of rights
Act. The SF–425, ordinarily mandated
in the revised OMB Circular A–102,
provides no accounting breakouts
necessary for proper stewardship.
Consequently, the proposed streamlined
form will substitute for the SF–425 and
will allow compliance monitoring and
proactive compliance maintenance and
technical assistance.
Submit written or electronic
comments on the collection of
information by August 23, 2012.
DATES:
Submit electronic
comments on the collection of
ADDRESSES:
information to:
Carla.Thomas@acf.hhs.gov. Submit
written comments on the collection of
information to Carla Thomas,
Administration on Intellectual and
Developmental Disabilities,
Administration on Community Living,
Washington, DC 20447 or by fax at (202)
205–8037.
FOR FURTHER INFORMATION CONTACT:
Jennifer Johnson at (202) 690–5982 or
Carla.Thomas@acf.hhs.gov.
In
compliance with 42 U.S.C. 1500 et seq.
(the DD Act), ACL/AIDD has submitted
the following proposed collection of
information to OMB for review and
clearance.
SUPPLEMENTARY INFORMATION:
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of responses per
respondent
Average
burden hours
per response
Total burden
hours
Financial Status Reporting Form for State Councils on Developmental Disabilities Program ..........................................................................................
55
3
5.10
841.5
Estimated Total Annual Burden
Hours: 841.5.
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–New and
title ‘‘Labeling of Certain Beers Subject
to the Labeling Jurisdiction of the Food
and Drug Administration.’’ Also include
the FDA docket number found in
brackets in the heading of this
document.
ADDRESSES:
Dated: July 19, 2012.
Kathy Greenlee,
Administrator & Assistant Secretary for
Aging.
[FR Doc. 2012–18019 Filed 7–23–12; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–D–0268]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Labeling of Certain
Beers Subject to the Labeling
Jurisdiction of the Food and Drug
Administration
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995
(the PRA).
DATES: Fax written comments on the
collection of information by August 23,
2012.
sroberts on DSK5SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
21:06 Jul 23, 2012
Jkt 226001
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400T, Rockville, MD 20850,
domini.bean@fda.hhs.gov.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Labeling of Certain Beers Subject to the
Labeling Jurisdiction of the Food and
Drug Administration—(OMB Control
Number 0910–New)
I. Background
In the Federal Register of August 17,
2009 (74 FR 41438) (the August 17,
2009, notice), FDA published a notice of
availability of the draft guidance
document entitled ‘‘Labeling of Certain
PO 00000
Frm 00108
Fmt 4703
Sfmt 4703
Beers Subject to the Labeling
Jurisdiction of the Food and Drug
Administration’’ (the draft guidance).
Persons with access to the Internet may
obtain the draft guidance at https://
www.fda.gov/FoodGuidances. This
guidance, when finalized, will provide
industry with information on how to
label beers that are subject to FDA’s
labeling laws and regulations. This draft
guidance was issued in light of the
ruling by the Alcohol and Tobacco Tax
and Trade Bureau (TTB) (formerly The
Bureau of Alcohol, Tobacco, and
Firearms (ATF)) clarifying that certain
beers do not meet the definition of a
‘‘malt beverage’’ under the Federal
Alcohol Administration Act (the FAA
Act). Because these beers are not subject
to the labeling provisions of the FAA
Act, they are subject to the labeling
provisions of the Federal Food, Drug,
and Cosmetic Act (the FD&C Act) and
the Fair Packaging and Labeling Act
(FPLA). FDA, in the draft guidance, also
reminds manufacturers that the labeling
of wine beverages containing less than
7 percent alcohol by volume, such as
wine coolers, diluted wine beverages,
dealcoholized or partially dealcoholized
wine and ciders, is also subject to FDA
labeling requirements.
As reflected in the 1987
Memorandum of Understanding
between FDA and TTB’s predecessor
Agency, the ATF (Ref. 1), TTB is
responsible for the issuance and
enforcement of regulations with respect
E:\FR\FM\24JYN1.SGM
24JYN1
43336
Federal Register / Vol. 77, No. 142 / Tuesday, July 24, 2012 / Notices
to the labeling of distilled spirits, wines,
and malt beverages under the FAA Act.
The TTB has clarified that certain
beers, which are not made from both
malted barley and hops but are instead
made from substitutes for malted barley
(such as sorghum, rice, or wheat) or are
made without hops, do not meet the
definition of a malt beverage under the
FAA Act. (See TTB Ruling 2008–3.)
(Ref. 2). TTB stated in its ruling that
such products (other than sake, which is
classified as a wine under the FAA Act)
are not subject to the labeling,
advertising, and other provisions of the
TTB regulations issued under the FAA
Act. Therefore, these beers are subject to
the labeling requirements under FDA’s
regulations. However, as explained in
the TTB ruling, some TTB labeling
requirements such as the Government
Health Warning Statement under the
Alcoholic Beverage Labeling Act and
certain marking requirements under the
Internal Revenue Code continue to
apply to these products.
The guidance is intended to assist
manufacturers in labeling beers that are
subject to FDA’s labeling laws and
regulations. In general, FDA requires
that food products under its labeling
jurisdiction be truthfully and
informatively labeled in accordance
with the FD&C Act and the FPLA, and
FDA’s implementing regulations. These
FDA labeling requirements are
explained in the guidance document.
In the August 17, 2009, notice, FDA
published a request for public comment
on the proposed collection of
information. FDA received one letter in
response to the notice, containing
multiple comments. Several comments
in this letter were generally supportive
of FDA’s information collection
provisions in the guidance. Additional
comments were outside the scope of the
four collection of information topics on
which the notice solicits comments and
will not be discussed in this document.
(Comment 1) One comment stated
that FDA should require alcohol content
labeling for the beers discussed in the
guidance, including the percent alcohol
by volume (%ABV); the amount of
alcohol (in fluid ounces (oz) or grams)
per serving; the definition of a
‘‘standard drink’’ (i.e., 12 fluid oz of
regular beer, 5 fluid oz of wine, or 1.5
fluid oz of 80-proof distilled spirits); the
number of standard drinks per
container; and, the advice on moderate
drinking, such as ‘‘The Dietary
Guidelines for Americans recommends
no more than one drink per day for
women, two drinks per day for men.’’
The comment stated that when a
consumer sees a beverage such as
‘‘sorghum beer’’ or ‘‘wheat beer’’ labeled
the same way that all other FDA
regulated beverages are labeled, the
consumer may not know that it is an
alcoholic beverage.
(Response) FDA appreciates the
concerns discussed in the comment. As
explained in the guidance, certain TTB
labeling requirements apply to these
products. For example, these non-malt
beers, like all alcohol beverages, are
required to bear the health warning
statement under the Alcoholic Beverage
Labeling Act (27 U.S.C. 213–215). FDA’s
guidance documents do not establish
legally enforceable requirements, and
therefore cannot include mandatory
language such as ‘‘shall, must, required,
or requirement’’ unless specific
regulatory or statutory requirements are
cited. To the extent that the comment
requests FDA to engage in rulemaking,
the comment is outside the scope of the
comment request on the four collection
of information topics as they relate to
the provisions of the draft guidance
document.
The guidance is intended to assist
manufacturers in labeling beers that are
subject to FDA’s labeling laws and
regulations. All labeling regulations
discussed in this guidance have been
previously approved by OMB in
accordance with the PRA under OMB
control number 0910–0381. The
regulations approved under OMB
control number 0910–0381 include
§§ 101.3, 101.4, 101.5, 101.9, 101.22,
and 101.105 (21 CFR 101.3, 101.4,
101.5, 101.9, 101.22, and 101.105). The
proposed information collection seeks
to add manufacturers of certain beers
that do not meet the definition of a
‘‘malt beverage’’ under the FAA Act as
new respondents to these labeling
regulations. The proposed information
collection also seeks OMB approval of
allergen labeling of these beers under
section 403(w)(1) of the FD&C Act (21
U.S.C. 343(w)(1)), which was added by
the Food Allergen Labeling and
Consumer Protection Act of 2004
(FALCPA).
Section 101.3 of FDA’s food labeling
regulations requires that the label of a
food product in packaged form bear a
statement of identity, (i.e., the name of
the product), including as appropriate,
the form of the food or the name of the
food imitated. Section 101.4 prescribes
the requirements for the declaration of
ingredients on the label or labeling of
food products in packaged form,
including using the common or usual
name of each ingredient. Section 101.5
requires that the label of a food product
in packaged form specify the name and
place of business of the manufacturer,
packer, or distributor and, if the food
producer is not the manufacturer of the
food product, its connection with the
food product. Section 101.9 requires
that nutrition information be provided
for all food products intended for
human consumption and offered for
sale, unless an exemption in § 101.9(j)
applies to the product. Section 101.22
contains labeling requirements for the
disclosure of spices, flavorings,
colorings, and chemical preservatives
(§ 101.22(j)) in food products. Section
101.105 specifies requirements for the
declaration of the net quantity of
contents on the label of a food in
packaged form.
Under the FD&C Act, as amended by
the FALCPA, the food source name of
any ‘‘major food allergen’’ present must
be declared (section 403(w)(1) of the
FD&C Act). Section 201(qq) of the FD&C
Act, (21 U.S.C. 321(qq)), defines ‘‘major
food allergen’’ as milk, egg, fish,
Crustacean shellfish, tree nuts, wheat,
peanuts, and soybeans, as well as any
food ingredient that contains protein
derived from one of them, with the
exception of highly refined oils.
Description of respondents: The
respondents to this collection of
information are manufacturers of beers
that are subject to FDA’s labeling laws
and regulations.
FDA estimates the burden of this
collection of information as follows:
sroberts on DSK5SPTVN1PROD with NOTICES
TABLE 1—ESTIMATED ANNUAL THIRD PARTY DISCLOSURE BURDEN 1
Number of
respondents
Citation
21
21
21
21
CFR
CFR
CFR
CFR
101.3
101.4
101.5
101.9
VerDate Mar<15>2010
and 101.22 .................................................
....................................................................
....................................................................
....................................................................
21:06 Jul 23, 2012
Jkt 226001
PO 00000
Frm 00109
Number of
disclosures
per
respondent
12
12
12
12
Fmt 4703
Sfmt 4703
Total annual
disclosures
2
2
2
2
E:\FR\FM\24JYN1.SGM
24
24
24
24
24JYN1
Average burden
per disclosure
0.5
1
0.25
4
Total hours
12
24
6
96
43337
Federal Register / Vol. 77, No. 142 / Tuesday, July 24, 2012 / Notices
TABLE 1—ESTIMATED ANNUAL THIRD PARTY DISCLOSURE BURDEN 1—Continued
Number of
respondents
Citation
Number of
disclosures
per
respondent
Total annual
disclosures
Average burden
per disclosure
Total hours
21 CFR 101.105 ................................................................
Section 403(w)(1) of the FD&C Act ...................................
Guidance document entitled ‘‘Labeling of Certain Beers
Subject to the Labeling Jurisdiction of the Food and
Drug Administration’’ ......................................................
12
12
2
2
24
24
0.5
1
12
24
12
1
12
1
12
Total ............................................................................
........................
........................
........................
sroberts on DSK5SPTVN1PROD with NOTICES
1 There
..........................
186
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA’s estimate of the number of
respondents in table 1 is based on the
number of regulatory submissions
submitted to TTB for beers that do not
meet the definition of a ‘‘malt beverage’’
under the FAA Act. Based on its records
of submissions received from
manufacturers of such products, TTB
estimates the number of respondents to
be 12 and the number of disclosures
annually to be 24. Thus, FDA adopts
TTB’s estimate of 12 respondents, and
an annual number of disclosures per
respondent of 2, in table 1 of this
document.
FDA’s estimate of the average burden
per disclosure for each regulation are
based on FDA’s experience with food
labeling under the Agency’s
jurisdiction. The estimated average
burden per disclosure for §§ 101.3,
101.4, 101.5, 101.9, 101.22, and 101.105
in table 1 are equal to, and based upon,
the estimated average burden per
disclosure approved by OMB in OMB
control number 0910–0381. FDA further
estimates that the labeling burden of
section 403(w)(1) of the FD&C Act,
which specifies requirements for the
declaration of food allergens, will be 1
hour based upon the similarity of the
requirements to that of § 101.4. Finally,
FDA estimates that a respondent will
spend 1 hour reading the guidance
document.
Thus, FDA estimates that 12
respondents will each label 2 products
annually, for a total of 24 labels. FDA
estimates that the manufacturers will
spend 7.25 hours (0.5 hours + 1 hour +
0.25 hour + 4 hours + 0.5 hour + 1 hour
= 7.25 hours) on each label to comply
with FDA’s labeling regulations and the
requirements of section 403(w)(1) of the
FD&C Act, for a total of 174 hours (24
labels × 7.25 hours = 174 hours). In
addition, 12 respondents will each
spend 1 hour reading the guidance
document, for a total of 12 hours. Thus,
FDA estimates the total hour burden of
the proposed collection of information
to be 186 hours (174 hours + 12 hours
= 186 hours).
VerDate Mar<15>2010
21:06 Jul 23, 2012
Jkt 226001
The draft guidance also refers to
previously approved collections of
information found in FDA regulations.
The collections of information in
§§ 101.3, 101.4, 101.5, 101.9, 101.22,
and 101.105 have been approved under
OMB control number 0910–0381.
II. References
The following references have been
placed on display in the Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, rm. 1061, Rockville, MD 20852,
and may be seen by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday. (FDA has verified the
Web site addresses, but we are not
responsible for any subsequent changes
to the Web sites after this document
publishes in the Federal Register.)
1. Memorandum of Understanding
225–88–2000 between FDA and Bureau
of Alcohol, Tobacco and Firearms,
available at https://www.fda.gov/
AboutFDA/PartnershipsCollaborations/
MemorandaofUnderstandingMOUs/
DomesticMOUs/ucm116370.htm.
2. TTB Ruling 2008–3 dated July 7,
2008, available at https://www.ttb.gov/
rulings/2008-3.pdf.
Dated: July 16, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012–18028 Filed 7–23–12; 8:45 am]
BILLING CODE 4160–01–P
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–1975–N–0336 (Formerly
75N–0184), FDA–1975–N–0355 (Formerly
75N–0185), FDA–1976–N–0272 (Formerly
76N–0056), FDA–1976–N–0344 (Formerly
76N–0057), FDA–1978–N–0701 (Formerly
78N–0070), FDA–1979–N–0224 (Formerly
79N–0169), FDA–1983–N–0297 (Formerly
83N–0030), and FDA–1988–N–0004
(Formerly 88N–0242); DESI 597, 1626, 3265,
10837, 12283, and 50213, and
Hydrocortisone Acetate and Pramoxine
Hydrochloride]
Drugs for Human Use; Drug Efficacy
Study Implementation; Certain
Prescription Drugs Offered for Various
Indications; Opportunity To Affirm
Outstanding Hearing Request
ACTION:
Notice.
The Food and Drug
Administration (FDA) is offering an
opportunity to affirm outstanding
hearing requests pertaining to several
dockets. FDA will assume that
companies with outstanding hearing
requests that do not respond to this
notice are no longer interested in
pursuing their requests, and will deem
the requests withdrawn.
DATES: Effective Date: This notice is
effective August 23, 2012.
Hearing Requests: Hearing requests
must be affirmed by notifying FDA by
August 23, 2012. Hearing requests not
affirmed within that timeframe will be
deemed withdrawn.
ADDRESSES: Requests to affirm or
withdraw outstanding hearing requests,
as well as all other communications in
response to this notice, should be
identified with the appropriate docket
number, and directed to Pamela Lee,
Office of Unapproved Drugs and
Labeling Compliance, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, rm. 5173,
Silver Spring, MD 20993–0002.
SUMMARY:
E:\FR\FM\24JYN1.SGM
24JYN1
Agencies
[Federal Register Volume 77, Number 142 (Tuesday, July 24, 2012)]
[Notices]
[Pages 43335-43337]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-18028]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-D-0268]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Labeling of Certain
Beers Subject to the Labeling Jurisdiction of the Food and Drug
Administration
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995 (the PRA).
DATES: Fax written comments on the collection of information by August
23, 2012.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-New and
title ``Labeling of Certain Beers Subject to the Labeling Jurisdiction
of the Food and Drug Administration.'' Also include the FDA docket
number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Information
Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400T,
Rockville, MD 20850, domini.bean@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Labeling of Certain Beers Subject to the Labeling Jurisdiction of the
Food and Drug Administration--(OMB Control Number 0910-New)
I. Background
In the Federal Register of August 17, 2009 (74 FR 41438) (the
August 17, 2009, notice), FDA published a notice of availability of the
draft guidance document entitled ``Labeling of Certain Beers Subject to
the Labeling Jurisdiction of the Food and Drug Administration'' (the
draft guidance). Persons with access to the Internet may obtain the
draft guidance at https://www.fda.gov/FoodGuidances. This guidance, when
finalized, will provide industry with information on how to label beers
that are subject to FDA's labeling laws and regulations. This draft
guidance was issued in light of the ruling by the Alcohol and Tobacco
Tax and Trade Bureau (TTB) (formerly The Bureau of Alcohol, Tobacco,
and Firearms (ATF)) clarifying that certain beers do not meet the
definition of a ``malt beverage'' under the Federal Alcohol
Administration Act (the FAA Act). Because these beers are not subject
to the labeling provisions of the FAA Act, they are subject to the
labeling provisions of the Federal Food, Drug, and Cosmetic Act (the
FD&C Act) and the Fair Packaging and Labeling Act (FPLA). FDA, in the
draft guidance, also reminds manufacturers that the labeling of wine
beverages containing less than 7 percent alcohol by volume, such as
wine coolers, diluted wine beverages, dealcoholized or partially
dealcoholized wine and ciders, is also subject to FDA labeling
requirements.
As reflected in the 1987 Memorandum of Understanding between FDA
and TTB's predecessor Agency, the ATF (Ref. 1), TTB is responsible for
the issuance and enforcement of regulations with respect
[[Page 43336]]
to the labeling of distilled spirits, wines, and malt beverages under
the FAA Act.
The TTB has clarified that certain beers, which are not made from
both malted barley and hops but are instead made from substitutes for
malted barley (such as sorghum, rice, or wheat) or are made without
hops, do not meet the definition of a malt beverage under the FAA Act.
(See TTB Ruling 2008-3.) (Ref. 2). TTB stated in its ruling that such
products (other than sake, which is classified as a wine under the FAA
Act) are not subject to the labeling, advertising, and other provisions
of the TTB regulations issued under the FAA Act. Therefore, these beers
are subject to the labeling requirements under FDA's regulations.
However, as explained in the TTB ruling, some TTB labeling requirements
such as the Government Health Warning Statement under the Alcoholic
Beverage Labeling Act and certain marking requirements under the
Internal Revenue Code continue to apply to these products.
The guidance is intended to assist manufacturers in labeling beers
that are subject to FDA's labeling laws and regulations. In general,
FDA requires that food products under its labeling jurisdiction be
truthfully and informatively labeled in accordance with the FD&C Act
and the FPLA, and FDA's implementing regulations. These FDA labeling
requirements are explained in the guidance document.
In the August 17, 2009, notice, FDA published a request for public
comment on the proposed collection of information. FDA received one
letter in response to the notice, containing multiple comments. Several
comments in this letter were generally supportive of FDA's information
collection provisions in the guidance. Additional comments were outside
the scope of the four collection of information topics on which the
notice solicits comments and will not be discussed in this document.
(Comment 1) One comment stated that FDA should require alcohol
content labeling for the beers discussed in the guidance, including the
percent alcohol by volume (%ABV); the amount of alcohol (in fluid
ounces (oz) or grams) per serving; the definition of a ``standard
drink'' (i.e., 12 fluid oz of regular beer, 5 fluid oz of wine, or 1.5
fluid oz of 80-proof distilled spirits); the number of standard drinks
per container; and, the advice on moderate drinking, such as ``The
Dietary Guidelines for Americans recommends no more than one drink per
day for women, two drinks per day for men.'' The comment stated that
when a consumer sees a beverage such as ``sorghum beer'' or ``wheat
beer'' labeled the same way that all other FDA regulated beverages are
labeled, the consumer may not know that it is an alcoholic beverage.
(Response) FDA appreciates the concerns discussed in the comment.
As explained in the guidance, certain TTB labeling requirements apply
to these products. For example, these non-malt beers, like all alcohol
beverages, are required to bear the health warning statement under the
Alcoholic Beverage Labeling Act (27 U.S.C. 213-215). FDA's guidance
documents do not establish legally enforceable requirements, and
therefore cannot include mandatory language such as ``shall, must,
required, or requirement'' unless specific regulatory or statutory
requirements are cited. To the extent that the comment requests FDA to
engage in rulemaking, the comment is outside the scope of the comment
request on the four collection of information topics as they relate to
the provisions of the draft guidance document.
The guidance is intended to assist manufacturers in labeling beers
that are subject to FDA's labeling laws and regulations. All labeling
regulations discussed in this guidance have been previously approved by
OMB in accordance with the PRA under OMB control number 0910-0381. The
regulations approved under OMB control number 0910-0381 include
Sec. Sec. 101.3, 101.4, 101.5, 101.9, 101.22, and 101.105 (21 CFR
101.3, 101.4, 101.5, 101.9, 101.22, and 101.105). The proposed
information collection seeks to add manufacturers of certain beers that
do not meet the definition of a ``malt beverage'' under the FAA Act as
new respondents to these labeling regulations. The proposed information
collection also seeks OMB approval of allergen labeling of these beers
under section 403(w)(1) of the FD&C Act (21 U.S.C. 343(w)(1)), which
was added by the Food Allergen Labeling and Consumer Protection Act of
2004 (FALCPA).
Section 101.3 of FDA's food labeling regulations requires that the
label of a food product in packaged form bear a statement of identity,
(i.e., the name of the product), including as appropriate, the form of
the food or the name of the food imitated. Section 101.4 prescribes the
requirements for the declaration of ingredients on the label or
labeling of food products in packaged form, including using the common
or usual name of each ingredient. Section 101.5 requires that the label
of a food product in packaged form specify the name and place of
business of the manufacturer, packer, or distributor and, if the food
producer is not the manufacturer of the food product, its connection
with the food product. Section 101.9 requires that nutrition
information be provided for all food products intended for human
consumption and offered for sale, unless an exemption in Sec. 101.9(j)
applies to the product. Section 101.22 contains labeling requirements
for the disclosure of spices, flavorings, colorings, and chemical
preservatives (Sec. 101.22(j)) in food products. Section 101.105
specifies requirements for the declaration of the net quantity of
contents on the label of a food in packaged form.
Under the FD&C Act, as amended by the FALCPA, the food source name
of any ``major food allergen'' present must be declared (section
403(w)(1) of the FD&C Act). Section 201(qq) of the FD&C Act, (21 U.S.C.
321(qq)), defines ``major food allergen'' as milk, egg, fish,
Crustacean shellfish, tree nuts, wheat, peanuts, and soybeans, as well
as any food ingredient that contains protein derived from one of them,
with the exception of highly refined oils.
Description of respondents: The respondents to this collection of
information are manufacturers of beers that are subject to FDA's
labeling laws and regulations.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Third Party Disclosure Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of
Number of disclosures Total annual Average burden
Citation respondents per disclosures per disclosure Total hours
respondent
----------------------------------------------------------------------------------------------------------------
21 CFR 101.3 and 101.22......... 12 2 24 0.5 12
21 CFR 101.4.................... 12 2 24 1 24
21 CFR 101.5.................... 12 2 24 0.25 6
21 CFR 101.9.................... 12 2 24 4 96
[[Page 43337]]
21 CFR 101.105.................. 12 2 24 0.5 12
Section 403(w)(1) of the FD&C 12 2 24 1 24
Act............................
Guidance document entitled 12 1 12 1 12
``Labeling of Certain Beers
Subject to the Labeling
Jurisdiction of the Food and
Drug Administration''..........
-------------------------------------------------------------------------------
Total....................... .............. .............. .............. .............. 186
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
FDA's estimate of the number of respondents in table 1 is based on
the number of regulatory submissions submitted to TTB for beers that do
not meet the definition of a ``malt beverage'' under the FAA Act. Based
on its records of submissions received from manufacturers of such
products, TTB estimates the number of respondents to be 12 and the
number of disclosures annually to be 24. Thus, FDA adopts TTB's
estimate of 12 respondents, and an annual number of disclosures per
respondent of 2, in table 1 of this document.
FDA's estimate of the average burden per disclosure for each
regulation are based on FDA's experience with food labeling under the
Agency's jurisdiction. The estimated average burden per disclosure for
Sec. Sec. 101.3, 101.4, 101.5, 101.9, 101.22, and 101.105 in table 1
are equal to, and based upon, the estimated average burden per
disclosure approved by OMB in OMB control number 0910-0381. FDA further
estimates that the labeling burden of section 403(w)(1) of the FD&C
Act, which specifies requirements for the declaration of food
allergens, will be 1 hour based upon the similarity of the requirements
to that of Sec. 101.4. Finally, FDA estimates that a respondent will
spend 1 hour reading the guidance document.
Thus, FDA estimates that 12 respondents will each label 2 products
annually, for a total of 24 labels. FDA estimates that the
manufacturers will spend 7.25 hours (0.5 hours + 1 hour + 0.25 hour + 4
hours + 0.5 hour + 1 hour = 7.25 hours) on each label to comply with
FDA's labeling regulations and the requirements of section 403(w)(1) of
the FD&C Act, for a total of 174 hours (24 labels x 7.25 hours = 174
hours). In addition, 12 respondents will each spend 1 hour reading the
guidance document, for a total of 12 hours. Thus, FDA estimates the
total hour burden of the proposed collection of information to be 186
hours (174 hours + 12 hours = 186 hours).
The draft guidance also refers to previously approved collections
of information found in FDA regulations. The collections of information
in Sec. Sec. 101.3, 101.4, 101.5, 101.9, 101.22, and 101.105 have been
approved under OMB control number 0910-0381.
II. References
The following references have been placed on display in the
Division of Dockets Management (HFA-305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville, MD 20852, and may be seen by
interested persons between 9 a.m. and 4 p.m., Monday through Friday.
(FDA has verified the Web site addresses, but we are not responsible
for any subsequent changes to the Web sites after this document
publishes in the Federal Register.)
1. Memorandum of Understanding 225-88-2000 between FDA and Bureau
of Alcohol, Tobacco and Firearms, available at https://www.fda.gov/AboutFDA/PartnershipsCollaborations/MemorandaofUnderstandingMOUs/DomesticMOUs/ucm116370.htm.
2. TTB Ruling 2008-3 dated July 7, 2008, available at https://www.ttb.gov/rulings/2008-3.pdf.
Dated: July 16, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-18028 Filed 7-23-12; 8:45 am]
BILLING CODE 4160-01-P